No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection.

Link to article at PubMed

Icon for Elsevier Science

No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection.

Med Mal Infect. 2020 Mar 30;:

Authors: Molina JM, Delaugerre C, Goff JL, Mela-Lima B, Ponscarme D, Goldwirt L, de Castro N

PMID: 32240719 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *